Cognoptix

company

About

Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.60M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active

Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.

The company was founded in 2001 and headquartered in Marlborough, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$21.60M
Cognoptix has raised a total of $21.60M in funding over 2 rounds. Their latest funding was raised on Sep 28, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 28, 2020 Series Unknown $2.60M 1 Detail
Oct 22, 2008 Series B $18.50M 1 Detail
Jan 23, 2006 Angel $500K 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Cognoptix is funded by 3 investors. Sidecar Fund2 and Rockport Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Sidecar Fund2 Series Unknown
Rockport Venture Partners Series B
Granite State Angels Angel